Retraction Watch

USC-Children’s Hospital Los Angeles researcher out following misconduct probe

An infectious diseases researcher found by a federal U.S. watchdog to have “recklessly” faked data in grants worth millions left his job as the investigation was coming to a close, Retraction Watch has learned.

As we reported last week, Prasadarao Nemani, of Children’s Hospital Los Angeles (CHLA) and the University of Southern California (USC), “engaged in research misconduct by recklessly including falsified and/or fabricated data” in a 2009 paper — retracted in 2018 — and four NIH grant applications, according to the U.S. Office of Research Integrity.

Earlier this week, in a statement provided to Retraction Watch, CHLA said that he was no longer with the hospital or with USC:

The positive case for suppression: A guest post from the editor in chief of Clarivate’s Web of Science

This is an invited guest post related to news about two suppression reversals announced today by Clarivate.

The research process is rarely straightforward. There are a myriad of ways in which it can go wrong, from the inception of a hypothesis that goes on to be disproved, to failed experiments and rejected manuscripts, hopefully ending in the “happily ever after” of adding to the scholarly record through publication and worldwide dissemination… before starting all over again. Being able to build on the corpus of existing knowledge is essential for future discoveries and innovation: As Newton wrote back in 1675 “If I have seen further, it is by standing upon the shoulders of giants.”

Sadly, we know that even once published, many scientific results are not easily reproducible, and some are amended or retracted. Fraud and misconduct might be the attention-grabbing explanations for the lack of reproducibility in research, but more often than not, it is honest mistakes or making decisions with inaccurate or incomplete information that lead to errata, corrigenda or retraction of articles. Many have argued we need to be more honest about this – and to see retraction as a good thing. Correction of the version of record should be embraced, rather than avoided, and the stigma surrounding retractions should be removed.

Why should the same not apply for suppression?

Major indexing service reverses decision to suppress two journals from closely followed metric

Following pushback from members of the taxonomy community, Clarivate Analytics, the company behind the Impact Factor, has reversed its decision to suppress two journals from receiving those scores this year.

As we reported in late June, Clarivate suppressed 33 journals from its Journal Citation Reports, which meant denying them an Impact Factor, for high levels of self-citation that boosted their scores and ranking. Many universities — controversially — rely on Impact Factor to judge the work of their researchers, so the move could have a dramatic effect on journals and the authors whose work appears in them.

As we reported earlier this month, at least three journals have appealed the move: Zootaxa, the International Journal of Systematic and Evolutionary Microbiology, and Body Image. Today, Clarivate announced it was reversing its decision on the two taxonomy journals, Zootaxa and the International Journal of Systematic and Evolutionary Microbiology.

In a statement, Clarivate said:

‘Some papers can slip through the net,’ says journal that published 5G-COVID-19 paper

We have heard back this morning from the publisher of a journal that yanked a paper that linked 5G cellphone technology and the novel coronavirus last week — a paper that scientific sleuth Elisabeth Bik mused was the “worst paper of 2020.”

The response to our request for comment from editor in chief Pio Conti reads a bit like a Mad Libs of excuses we hear from publishers when something goes wrong. Read carefully for:

High-profile sleep researcher loses paper for duplication

A prominent sleep researcher whose work has come under intense scrutiny has lost a paper for duplication, aka self-plagiarism.

Matthew Walker, of UC Berkeley, is the author of Why We Sleep, a bestselling treatise on the many woes of fatigue. Instantly popular, it was touted everywhere, from Bill Gates to The New York Times, which enthused:

Hundreds petition to retract paper they call “unscholarly, overtly racist” and full of “racially violent narratives”

Hundreds of academics, anti-poverty advocates and others have signed petitions demanding the journal Society retract a new commentary which argues, in essence, that poor Black and Hispanic people in the United States are poor because they haven’t figured out how to be more white.

One petition, to the editor of the journal, Jonathan Imber, had garnered more than 550 signatories by the time of this writing. Another, to the author of the paper, the editorial board of the journal, and the CEO of Springer Nature, which publishes the journal, was at 400 and counting.

The essay, by Lawrence Mead, a public policy researcher at New York University, argues that racism and a lack of good jobs do not explain why America, the world’s richest country, continues to have a problem with poverty. “More plausible,” Mead states, are differences in “culture”:

Blaming “overflow of manuscripts” and “obviously biased” reviewers, journal will retract homeopathy-COVID-19 paper

A public health journal will be retracting a paper that argued for the adoption of homeopathy in the fight against the coronavirus pandemic, according to the editor in chief.

We reported on Saturday that the Journal of Public Health: From Theory to Practice, a Springer Nature title also known by its German name, Zeitschrift für Gesundheitswissenschaften, had published “Homeopathy combat against coronavirus disease (Covid-19)” on June 5.

At the time, we had not yet heard from Joachim Kugler, the journal’s editor, about how this might have happened. Today, Kugler told Retraction Watch:

“[A] painful step”: Authors retract paper on fatal poultry virus

The authors of a 2019 paper on a lethal type of poultry virus in Asia have retracted the article because of problems with the data collection. But the researchers stand by their findings, which, they say, suggest the pathogen could be harmful to humans.

The paper, titled “Novel orthobunyavirus causing severe kidney disease in broiler chickens, Malaysia, 2014-2017,” appeared in Emerging Infectious Diseases, a publication of the U.S. Centers for Disease Control and Prevention.

The authors were affiliated with Ceva-Phylaxia Veterinary Biologicals Co. Ltd., and the Hungarian Academy of Sciences, both in Budapest. The lead author was Vilmos Palya, a prominent veterinary scientist.

According to the abstract of the article:

Paper blaming COVID-19 on 5G technology withdrawn

A paper which argued that 5G cellphone technology could lead to infection with the novel coronavirus has been retracted, but not before scientific sleuth Elisabeth Bik wondered whether it was the “worst paper of 2020.”

The article, “5G Technology and induction of coronavirus in skin cells,” came from a group from Italy, the United States and Russia, and appeared in the Journal of Biological Regulators and Homeostatic Agents. The journal is published by Biolife, which asserts that it’s peer reviewed but has not responded to a request for comment. [Please see an update on this post.]

The abstract is now marked “WITHDRAWN” on PubMed and the paper has disappeared from the journal’s website. The abstract has been preserved here. According to the authors:

Paper urging use of homeopathy for COVID-19 appears in peer-reviewed public health journal

A peer-reviewed journal has published a paper that urges the adoption of homeopathy in the fight against the coronavirus pandemic.

[Please see an update on this post.]

The Journal of Public Health: From Theory to Practice — published by Springer Nature and also known by its German name, Zeitschrift für Gesundheitswissenschaften — published “Homeopathy combat against coronavirus disease (Covid-19)” on June 5. It is indexed in PubMed Central, although not on Medline.

Here’s the abstract:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: